Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China | |
Xu, Yan; Mao, Ningying; Chirikov, Viktor; Du, Fen; Yeh, Yu-Chen; Liu, Li; Liu, Ruiqi; Gao, Xin | |
2019 | |
卷号 | 39期号:3页码:331-340 |
ISSN号 | 1173-2563 |
DOI | 10.1007/s40261-019-00750-3 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6344884 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Xu, Yan,Mao, Ningying,Chirikov, Viktor,et al. Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China[J],2019,39(3):331-340. |
APA | Xu, Yan.,Mao, Ningying.,Chirikov, Viktor.,Du, Fen.,Yeh, Yu-Chen.,...&Gao, Xin.(2019).Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China.,39(3),331-340. |
MLA | Xu, Yan,et al."Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China".39.3(2019):331-340. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论